Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Catteau, W. Harris, Chun-Fang Xu, E. Solomon (1999)
Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristicsOncogene, 18
R. Scully, Junjie Chen, A. Plug, Yonghong Xiao, D. Weaver, J. Feunteun, T. Ashley, D. Livingston (1997)
Association of BRCA1 with Rad51 in Mitotic and Meiotic CellsCell, 88
M. Thompson, R. Jensen, P. Obermiller, D. Page, J. Holt (1995)
Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progressionNature Genetics, 9
T. Sørlie, C. Perou, R. Tibshirani, T. Aas, S. Geisler, H. Johnsen, T. Hastie, M. Eisen, M. Rijn, S. Jeffrey, T. Thorsen, H. Quist, J. Matese, P. Brown, D. Botstein, P. Lønning, A. Børresen-Dale (2001)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences of the United States of America, 98
J. Herman, J. Graff, S. Myöhänen, B. Nelkin, S. Baylin (1996)
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.Proceedings of the National Academy of Sciences of the United States of America, 93 18
J. Vaughn, P. Davis, Marcus Jarboe, G. Huper, A. Evans, R. Wiseman, A. Berchuck, J. Iglehart, P. Futreal, J. Marks (1996)
BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells.Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 7 6
I. Krop, P. Maguire, J. Lahti-Domenici, Gabriela Lodeiro, A. Richardson, H. Johannsdottir, H. Nevanlinna, Å. Borg, R. Gelman, R. Barkardottir, A. Lindblom, K. Polyak (2003)
Lack of HIN-1 methylation in BRCA1-linked and "BRCA1-like" breast tumors.Cancer research, 63 9
J. Rice, H. Ozçelik, H. Ozçelik, Patrick Maxeiner, I. Andrulis, I. Andrulis, B. Futscher (2000)
Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens.Carcinogenesis, 21 9
D. Porter, I. Krop, S. Nasser, D. Sgroi, C. Kaelin, J. Marks, G. Riggins, K. Polyak (2001)
A SAGE (serial analysis of gene expression) view of breast tumor progression.Cancer research, 61 15
P. Futreal, Qingyun Liu, D. Shattuck-Eidens, C. Cochran, K. Harshman, S. Tavtigian, L. Bennett, A. Haugen-Strano, J. Swensen, Y. Miki, K. Eddington, M. Mcclure, C. Frye, J. Weaver-Feldhaus, W. Ding, Z. Gholami, P. Söderkvist, L. Terry, S. Jhanwar, A. Berchuck, J. Iglehart, J. Marks, D. Ballinger, J. Barrett, M. Skolnick, M. Skolnick, A. Kamb, R. Wiseman (1994)
BRCA1 mutations in primary breast and ovarian carcinomas.Science, 266 5182
T. Sørlie, R. Tibshirani, Joel Parker, T. Hastie, J. Marron, A. Nobel, Shibing Deng, H. Johnsen, Robert Pesich, S. Geisler, J. Demeter, C. Perou, P. Lønning, P. Brown, A. Børresen-Dale, D. Botstein (2003)
Repeated observation of breast tumor subtypes in independent gene expression data setsProceedings of the National Academy of Sciences of the United States of America, 100
Lei Zheng, L. Annab, C. Afshari, Wen-Hwa Lee, T. Boyer (2001)
BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptorProceedings of the National Academy of Sciences of the United States of America, 98
W. Highsmith, Q. Jin, A. Nataraj, Jacquelyn O'Connor, V. Burland, Wendy Baubonis, F. Curtis, N. Kusukawa, M. Garner (1999)
Use of a DNA toolbox for the characterization of mutation scanning methods. I: Construction of the toolbox and evaluation of heteroduplex analysisELECTROPHORESIS, 20
Cindy Wilson, Lillian Ramos, M. Villasenor, K. Anders, M. Press, Kathy Clarke, B. Karlan, Junjie Chen, R. Scully, D. Livingston, R. Zuch, M. Kanter, Sylvan Cohen, F. Calzone, D. Slamon (1999)
Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomasNature Genetics, 21
J. Rice, K. Massey-Brown, B. Futscher (1998)
Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cellsOncogene, 17
R. Wang, C. Gehrke, M. Ehrlich (1980)
Comparison of bisulfite modification of 5-methyldeoxycytidine and deoxycytidine residues.Nucleic acids research, 8 20
J. Sudbø, A. Reith, O. Lingjaerde (2001)
Gene-expression profiles in hereditary breast cancer.The New England journal of medicine, 344 26
K. Miyamoto, T. Fukutomi, K. Asada, K. Wakazono, H. Tsuda, T. Asahara, T. Sugimura, T. Ushijima (2002)
Promoter hypermethylation and post-transcriptional mechanisms for reduced BRCA1 immunoreactivity in sporadic human breast cancers.Japanese journal of clinical oncology, 32 3
Y. Niwa, T. Oyama, T. Nakajima (2000)
BRCA1 Expression Status in Relation to DNA Methylation of the BRCA1 Promoter Region in Sporadic Breast CancersJapanese Journal of Cancer Research : Gann, 91
O. Johannsson, I. Idvall, C. Anderson, Å. Borg, R. Barkardottir, V. Egilsson, Hampus Olsson (1997)
Tumour biological features of BRCA1-induced breast and ovarian cancer.European journal of cancer, 33 3
S. Staff, J. Isola, M. Tanner (2003)
Haplo-insufficiency of BRCA1 in sporadic breast cancer.Cancer research, 63 16
P. Rio, J. Maurizis, Monique Latour, Y. Bignon, D. Bernard-Gallon (1999)
Quantification of BRCA1 protein in sporadic breast carcinoma with or without loss of heterozygosity of the BRCA1 geneInternational Journal of Cancer, 80
Z. Wang, Ming Lin, Lee-Jen Wei, Cheng Li, A. Miron, Gabriella Lodeiro, L. Harris, Sridhar Ramaswamy, D. Tanenbaum, M. Meyerson, J. Iglehart, A. Richardson (2004)
Loss of Heterozygosity and Its Correlation with Expression Profiles in Subclasses of Invasive Breast CancersCancer Research, 64
T. Taniguchi, M. Tischkowitz, N. Ameziane, S. Hodgson, C. Mathew, H. Joenje, S. Mok, A. D’Andrea (2003)
Disruption of the Fanconi anemia–BRCA pathway in cisplatin-sensitive ovarian tumorsNature Medicine, 9
A. Bhattacharyya, Uy Ear, B. Koller, R. Weichselbaum, D. Bishop (2000)
The Breast Cancer Susceptibility Gene BRCA1 Is Required for Subnuclear Assembly of Rad51 and Survival following Treatment with the DNA Cross-linking Agent Cisplatin*The Journal of Biological Chemistry, 275
S. Signoretti, L. Marcotullio, A. Richardson, Sridhar Ramaswamy, Beth Isaac, M. Rue, F. Monti, M. Loda, M. Pagano (2002)
Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer.The Journal of clinical investigation, 110 5
P. Warnecke, C. Stirzaker, John Melki, D. Millar, Cheryl Paul, Sue Clark, Sue Clark (1997)
Detection and measurement of PCR bias in quantitative methylation analysis of bisulphite-treated DNA.Nucleic acids research, 25 21
R. Scully, S. Anderson, D. Chao, Wanjiang Wei, Liyan Ye, R. Young, D. Livingston, J. Parvin (1997)
BRCA1 is a component of the RNA polymerase II holoenzyme.Proceedings of the National Academy of Sciences of the United States of America, 94 11
R. Scully, S. Ganesan, M. Brown, J. Caprio, S. Cannistra, J. Feunteun, S. Schnitt, D. Livingston, Y. Chen, P.-L. Chen, D. Riley, W.-H. Lee, D. Allred, C. Osborne (1996)
Location of BRCA1 in Human Breast and Ovarian Cancer CellsScience, 272
S. Lakhani, M. Vijver, J. Jacquemier, T. Anderson, P. Osin, L. McGuffog, D. Easton (2002)
The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 20 9
A. Pérez‐Vallés, Miguel Martorell‐Cebollada, E. Nogueira‐Vázquez, J. García-García, E. Fuster-Diana (2001)
The usefulness of antibodies to the BRCA1 protein in detecting the mutated BRCA1 gene. An immunohistochemical studyJournal of Clinical Pathology, 54
C. Perou, T. Sørlie, M. Eisen, M. Rijn, S. Jeffrey, Christian Rees, J. Pollack, D. Ross, H. Johnsen, L. Akslen, Ø. Fluge, Alexander Pergamenschikov, Cheryl Williams, Shirley Zhu, P. Lønning, A. Børresen-Dale, P. Brown, D. Botstein (2000)
Molecular portraits of human breast tumoursNature, 406
A. Miron, J. Schildkraut, B. Rimer, E. Winer, C. Skinner, P. Futreal, D. Culler, B. Calingaert, S. Clark, P. Marcom, J. Iglehart (2000)
Testing for hereditary breast and ovarian cancer in the southeastern United States.Annals of surgery, 231 5
L. Veer, H. Dai, M. Vijver, Yudong He, A. Hart, M. Mao, H. Peterse, K. Kooy, M. Marton, A. Witteveen, G. Schreiber, R. Kerkhoven, C. Roberts, P. Linsley, R. Bernards, S. Friend (2002)
Gene expression profiling predicts clinical outcome of breast cancerNature, 415
J. Gudas, Tao Li, Hoang-Lan Nguyen, D. Jensen, F. Rauscher, K. Cowan (1996)
Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells.Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 7 6
K. Yoshikawa, K. Honda, T. Inamoto, H. Shinohara, Akira Yamauchi, Kenji Suga, T. Okuyama, T. Shimada, H. Kodama, S. Noguchi, A. Gazdar, Yoshio Yamaoka, R. Takahashi (1999)
Reduction of BRCA1 protein expression in Japanese sporadic breast carcinomas and its frequent loss in BRCA1-associated cases.Clinical cancer research : an official journal of the American Association for Cancer Research, 5 6
P. Chappuis, J. Goffin, N. Wong, C. Perret, P. Ghadirian, P. Tonin, W. Foulkes (2002)
A significant response to neoadjuvant chemotherapy in BRCA1/2 related breast cancerJournal of Medical Genetics, 39
M. Esteller, M. Fraga, Min Guo, J. García-Foncillas, I. Hedenfalk, A. Godwin, J. Trojan, C. Vaurs-Barrière, Y. Bignon, S. Ramus, J. Benítez, T. Caldés, Y. Akiyama, Yusuhito Yuasa, V. Launonen, M. Cañal, Roberto Rodríguez, G. Capellá, M. Peinado, Å. Borg, L. Aaltonen, B. Ponder, S. Baylin, J. Herman (2001)
DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis.Human molecular genetics, 10 26
N. Turner, A. Tutt, A. Ashworth (2004)
Hallmarks of 'BRCAness' in sporadic cancersNature Reviews Cancer, 4
M. Esteller, Jose Silva, G. Domínguez, F. Bonilla, X. Matías-Guiu, E. Lerma, E. Bussaglia, J. Prat, I. Harkes, E. Repasky, E. Gabrielson, M. Schutte, S. Baylin, J. Herman (2000)
Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.Journal of the National Cancer Institute, 92 7
Yumay Chen, Chi‐Fen Chen, D. Riley, D. Allred, Phang-lang Chen, Daniel Hoff, C. Osborne, Wen-Hwa Lee (1995)
Aberrant Subcellular Localization of BRCA1 in Breast CancerScience, 270
J.CIark Susan, J. Harrison, C. Paul, M. Frommer (1994)
High sensitivity mapping of methylated cytosines.Nucleic acids research, 22 15
Yi Wang, D. Cortez, P. Yazdi, N. Neff, S. Elledge, J. Qin (2000)
BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures.Genes & development, 14 8
H. Özçelik, M. To, J. Couture, S. Bull, I. Andrulis (1998)
Preferential allelic expression can lead to reduced expression of BRCA1 in sporadic breast cancersInternational Journal of Cancer, 77
M. Frommer, L. McDonald, D. Millar, C. Collis, F. Watt, G. Grigg, P. Molloy, C. Paul (1992)
A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands.Proceedings of the National Academy of Sciences of the United States of America, 89
F. Magdinier, S. Ribieras, G. Lenoir, L. Frappart, R. Dante (1998)
Down-regulation of BRCA1 in human sporadic breast cancer; analysis of DNA methylation patterns of the putative promoter regionOncogene, 17
T. Ganguly, R. Dhulipala, L. Godmilow, A. Ganguly (1998)
High throughput fluorescence-based conformation-sensitive gel electrophoresis (F-CSGE) identifies six unique BRCA2 mutations and an overall low incidence of BRCA2 mutations in high-risk BRCA1-negative breast cancer familiesHuman Genetics, 102
BRCA1 is a tumor suppressor gene that functions in DNA repair. Basal-like tumors are a distinctive subtype of breast cancer defined by gene expression profiles. Hereditary BRCA1 breast tumors and basal-like sporadic tumors have a similar phenotype and gene expression signature, suggesting involvement of BRCA1 in the pathogenesis of sporadic basal-like cancer. This study evaluates the role of BRCA1 in sporadic breast tumorigenesis. BRCA1 protein expression and promoter methylation are compared to tumor histopathology and gene expression profiles. We find BRCA1 protein expression correlates with tumor mitotic rate, consistent with normal cell-cycle regulation of the BRCA1 gene. Methylation is found in 21% of tumors and is associated with lower BRCA1 protein, but not with specific pathologic features. Basal-like tumors, defined by hierarchical clustering of gene expression, have infrequent BRCA1 methylation and high levels of BRCA1 protein expression consistent with their high mitotic rate. Tumors with BRCA1 promoter methylation are present in all expression clusters; however, a subgroup of ER-positive high-grade tumors has a significantly greater number of BRCA1 methylated tumors. Absence of BRCA1 promoter methylation and high levels of BRCA1 expression in basal-like sporadic tumors suggest alternate explanations for the phenotypic similarities of these tumors to hereditary BRCA1 tumors.
Breast Cancer Research and Treatment – Springer Journals
Published: Dec 14, 2004
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.